Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0M8Y5 | ISIN: BE0003878957 | Ticker-Symbol: 4V1
Tradegate
17.01.25
21:05 Uhr
75,00 Euro
-1,70
-2,22 %
Branche
Immobilien
Aktienmarkt
BEL Mid
1-Jahres-Chart
VGP NV Chart 1 Jahr
5-Tage-Chart
VGP NV 5-Tage-Chart
RealtimeGeldBriefZeit
76,5076,8021.01.
76,6076,8021.01.
GlobeNewswire (Europe)
199 Leser
Artikel bewerten:
(1)

VGP NV: VGP Trading Update

Finanznachrichten News

PRESS RELEASE
Regulated Information - inside information

10 May 2024, 7:00 am, Antwerp, Belgium: VGP NV ('VGP' or 'the Group') today published its trading update for the first four months of 2024, reporting important milestones and solid growth:

  • 31.9 million of new and renewed leases signed year-to-date bringing the annualised committed leases for the year to date to €376.2 million1 (+ € 25.4 million compared to 31 December 2023, which is +7% YTD and +17% y-o-y). VGP has been able to conclude a number of iconic lease agreements, predominantly in the industrial segment in Western Europe, and is negotiating on a significant pipeline of additional pre-let projects.
  • 33 projects under construction representing 861,000 square meters (of which 11 projects totalling 188,000 square meters started up during the year) and 56.7 million in additional annual rent once fully built and let. The pipeline under construction is 71.6% pre-let. The pre-let of assets longer than six months under construction amounts to 81.3% to date. VGP estimates to initiate over 300,000 sqm of developments in the first half of '24.
  • 4 projects delivered representing 101,000 square meters, or € 7.1 million in additional annual rent, currently fully let and a further 89,000 square meters estimated for delivery in the remainder of the first half of 2024.
  • Total secured development land bank stands at 8.4 million square meters at the end of April 2024 representing a development potential of over 3.7 million square meters. 286,000 square meters of new development land was acquired during the first four months of the year with the acquisitions including, amongst others, VGP's inaugural landplot in Vejle, Denmark. Several other land acquisition projects are in the pipeline.
  • Completed property portfolio2 virtually fully let with occupancy at 99% as of 30 April 2024 (compared to 99 % as at 31 December 2023). Of the € 376.2 million committed annualized rental income, € 316.2 has become cash generative, an increase of 4% versus December 2023. Another € 40.5 million² of rental income is expected to start within the next twelve months.
  • Effectuated several transactions resulting in enhanced liquidity by € 797 million:
    1. Executed first closing with Areim and second closing with Deka, resulting in gross proceeds of € 489 million;
    2. Disposal of the Development Joint Venture LPM Moerdijk, which resulted in € 173 million of gross proceeds;
    3. Financing of VGP Renewable Energy enabled VGP to draw € 135 million at attractive conditions.
  • Operational PV capacity has further increased during the first four months of 2024 with 91 projects completed delivering 121.4MWp compared to 101.8 MWp as of Dec-23 (+18.8% YTD).
  • As per May 10th, VGP will host its annual general shareholders meeting at its headquarters in Antwerp. Amongst others the shareholders will vote on a dividend pay-out of € 101 million, or
    € 3.70 per share.
  • As per April 9th, VGP published its Annual Report 2023, including the Corporate Responsibility Report showcasing VGP's steps taken and KPI's set as part of the Group's ESG strategy.

See the full press release in the attachment



1 Including Joint Ventures at 100%. As at 30 April 2024 the annualized committed leases of the Joint Ventures stood at €275.3 million.

2 Including Joint Ventures at 100%.



© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.